fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ECCO 2018: Evolving concepts of IBD pathogenesis

Written by | 1 Mar 2018

Perianal fistula is a debilitating complication in CD which affects up to 50% of patients in the course of their disease…

ECCO 2018: Novel treatments in IBD

Written by | 11 Feb 2018

The current research and development pipeline of novel biologic therapies and small molecule drugs promises improved efficacy and safety in the treatment of IBD in the near future…. read more.

'Brain training' app boosts memory in dementia patients

Written by | 8 Sep 2017

Author: Gary Finnegan A ‘brain training’ game developed by researchers at the University of Cambridge, UK, could help improve the memory of patients in the very earliest stages… read more.

ICML 2017: The role of stem cell transplantation for lymphoma in 2017

Written by | 11 Jul 2017

By Maria Dalby (article) and Esther Drain (interviews) Even in an era of rapid progress in terms of new agents and treatment approaches, stem cell transplantation (SCT) continues… read more.

Over 1000 studies available in EU register of approved drugs

Written by | 18 Apr 2017

The 1,000th study has been uploaded to the European Union (EU) electronic Register of Post-Authorisation Studies (EU PAS Register), a significant landmark in the transparency initiative.

BSH 2017: How I treat molecular high-risk myeloma – what can we do, what should we do?

Written by | 6 Apr 2017

High-risk multiple myeloma (MM) continues to pose a challenge to haematologists both in terms of diagnostics and therapy. Opening the UK Myeloma Forum at the 2017 BSH annual… read more.

Vulnerable patients: burning questions in IBD

Written by | 30 Mar 2017

An interesting session at ECCO dealt with the patients for whom there is sparce data to guide their treatment – experts in the field gave their guidance to… read more.

New compounds in the treatment of IBD (ECCO 2017)

Written by | 17 Mar 2017

Never before in the history of IBD have there been so many promising compounds in the pipeline. In a scientific session dedicated to new compounds, leading investigators discussed… read more.

Clinical trials vs real life

Written by | 15 Mar 2017

Dr Filip Baert (Roeselare, Belgium) gives a summary of his session on trial endpoints vs therapeutic objectives. he also discusses the role of ECCO in improving the data generated in… read more.

Benefits of careful monitoring of chronic pain patients

Written by | 11 Aug 2016

Within the past 10 years, the prescription of opioids for the treatment of chronic pain has increased and the abuse of opioid medications leading to addiction has been… read more.

EHA 2016: Consolidation and maintenance therapy for multiple myeloma: is it the new standard? Professor Paul Richardson (Harvard Medical School, Boston, USA) and Professor Maria-Victoria Mateos (Salamanca, Spain) discuss the meta-analysis of OS in myeloma with maintenance therapy presented at ASCO and EHA this year, along with strategies for continuous therapies

Written by | 3 Aug 2016

Consolidation and maintenance therapy for multiple myeloma: is it the new standard?   Professor Antonio Palumbo (University of Turin, Italy) and Professor Paul Richardson (Harvard Medical School, Boston,… read more.

EHA 2016: A new multiple myeloma classification system that correlates to disease stage and prognosis

Written by | 29 Jul 2016

Hans Erik Johnsen, Aalborg University Hospital, Denmark. by Maria Dalby:  The gene expression profiles of myeloma plasma cells in the normal bone marrow can be used for defining… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.